Thyroid cancer after exposure to radioactive ¹³¹I

By Holm Lars-Erik  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1037-1040

Informa Healthcare

Access to resources Recommend Favorite

Effects of recombinant human thyroid stimulating hormone on 131I therapy for the treatment of differentiated thyroid cancer

By Guo Yiling   Zhang Yingnan   Chen Zuowei   Xin Zhenfu  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-05 ,pp. : 1847-1850

Spandidos Publications

Access to resources Recommend Favorite

Comparison of Thyroid Function in Mice after Various Injected Activities of ¹²³I, ¹²⁵I and ¹³¹I

By Van Best J.A.  

International Journal of Radiation Biology, Vol. 42, Iss. 5, 1982-11 ,pp. : 545-557

Informa Healthcare

Access to resources Recommend Favorite

Micronuclei in lymphocytes of children from the vicinity of Chernobyl before and after 131I therapy for thyroid cancer

By Wuttke K.   Streffer C.   Ller W.-U. Mu   Reiners C.   Biko J.   Demidchik E.  

International Journal of Radiation Biology, Vol. 69, Iss. 2, 1996-02 ,pp. : 259-268

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of whole-body retention of iodine-131 (131I) after postoperative remnant ablation for differentiated thyroid carcinoma – thyroxine withdrawal versus rhTSH administration: A retrospective comparison

By      

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 617-620

Spandidos Publications

Access to resources Recommend Favorite